AU4952885A

AU4952885A – Lipsomes and compositions of sterol derivatives
– Google Patents

AU4952885A – Lipsomes and compositions of sterol derivatives
– Google Patents
Lipsomes and compositions of sterol derivatives

Info

Publication number
AU4952885A

AU4952885A
AU49528/85A
AU4952885A
AU4952885A
AU 4952885 A
AU4952885 A
AU 4952885A
AU 49528/85 A
AU49528/85 A
AU 49528/85A
AU 4952885 A
AU4952885 A
AU 4952885A
AU 4952885 A
AU4952885 A
AU 4952885A
Authority
AU
Australia
Prior art keywords
lipsomes
compositions
sterol derivatives
sterol
derivatives
Prior art date
1985-04-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU49528/85A
Other versions

AU596953B2
(en

Inventor
Lois E. Bolcsak
Andrew Stuart Janoff
Mircea Constantine Popescu
Christine E. Swenson
Paul A. Tremblay
Alan Lee Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Elan Pharmaceuticals LLC

Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1985-04-10
Filing date
1985-10-10
Publication date
1986-11-05

1985-04-10
Priority claimed from US06/721,630
external-priority
patent/US4721612A/en

1985-10-10
Application filed by Liposome Co Inc
filed
Critical
Liposome Co Inc

1986-11-05
Publication of AU4952885A
publication
Critical
patent/AU4952885A/en

1990-05-24
Application granted
granted
Critical

1990-05-24
Publication of AU596953B2
publication
Critical
patent/AU596953B2/en

2005-10-10
Anticipated expiration
legal-status
Critical

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/10—Dispersions; Emulsions

A61K9/127—Liposomes

A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/10—Dispersions; Emulsions

A61K9/127—Liposomes

A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P31/04—Antibacterial agents

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K39/00—Medicinal preparations containing antigens or antibodies

A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

A61K2039/55511—Organic adjuvants

A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC

Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10S436/00—Chemistry: analytical and immunological testing

Y10S436/829—Liposomes, e.g. encapsulation

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC

Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

Y10T428/00—Stock material or miscellaneous articles

Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof

Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Y10T428/2984—Microcapsule with fluid core [includes liposome]

AU49528/85A
1985-04-10
1985-10-10
Lipsomes and compositions of sterol derivatives

Expired

AU596953B2
(en)

Applications Claiming Priority (4)

Application Number
Priority Date
Filing Date
Title

US721630

1985-04-10

US06/721,630

US4721612A
(en)

1984-04-12
1985-04-10
Steroidal liposomes

US06/773,429

US4891208A
(en)

1985-04-10
1985-09-10
Steroidal liposomes

US773429

1985-09-10

Related Child Applications (1)

Application Number
Title
Priority Date
Filing Date

AU44345/89A
Division

AU609647B2
(en)

1985-04-10
1989-11-02
Pharmaceutical compositions containing salts of cholesterol hemisuccinate

Publications (2)

Publication Number
Publication Date

AU4952885A
true

AU4952885A
(en)

1986-11-05

AU596953B2

AU596953B2
(en)

1990-05-24

Family
ID=27110456
Family Applications (2)

Application Number
Title
Priority Date
Filing Date

AU49528/85A
Expired

AU596953B2
(en)

1985-04-10
1985-10-10
Lipsomes and compositions of sterol derivatives

AU44345/89A
Expired

AU609647B2
(en)

1985-04-10
1989-11-02
Pharmaceutical compositions containing salts of cholesterol hemisuccinate

Family Applications After (1)

Application Number
Title
Priority Date
Filing Date

AU44345/89A
Expired

AU609647B2
(en)

1985-04-10
1989-11-02
Pharmaceutical compositions containing salts of cholesterol hemisuccinate

Country Status (16)

Country
Link

US
(1)

US4891208A
(en)

EP
(1)

EP0222771A4
(en)

JP
(1)

JPH0798741B2
(en)

KR
(1)

KR890001882B1
(en)

AU
(2)

AU596953B2
(en)

CA
(1)

CA1262334A
(en)

DK
(1)

DK591086A
(en)

ES
(2)

ES8700933A1
(en)

FI
(1)

FI92463C
(en)

HU
(1)

HU203205B
(en)

IE
(1)

IE66709B1
(en)

IL
(1)

IL76600A
(en)

NO
(1)

NO173213C
(en)

NZ
(1)

NZ213601A
(en)

PT
(1)

PT81242B
(en)

WO
(1)

WO1986005977A1
(en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US5916588A
(en)

*

1984-04-12
1999-06-29
The Liposome Company, Inc.
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use

US5231112A
(en)

*

1984-04-12
1993-07-27
The Liposome Company, Inc.
Compositions containing tris salt of cholesterol hemisuccinate and antifungal

US6090406A
(en)

*

1984-04-12
2000-07-18
The Liposome Company, Inc.
Potentiation of immune responses with liposomal adjuvants

US5736155A
(en)

*

1984-08-08
1998-04-07
The Liposome Company, Inc.
Encapsulation of antineoplastic agents in liposomes

US5041278A
(en)

*

1985-10-15
1991-08-20
The Liposome Company, Inc.
Alpha tocopherol-based vesicles

US4861580A
(en)

*

1985-10-15
1989-08-29
The Liposome Company, Inc.
Composition using salt form of organic acid derivative of alpha-tocopheral

JPH0761940B2
(en)

*

1986-11-17
1995-07-05
株式会社資生堂

Liposomal formulation for outer skin

US5009819A
(en)

*

1987-11-12
1991-04-23
The Liposome Company, Inc.
Taste moderating composition

AU627226B2
(en)

*

1988-08-25
1992-08-20
Liposome Company, Inc., The
Influenza vaccine and novel adjuvants

NZ230424A
(en)

*

1988-08-25
1992-05-26
Liposome Co Inc
Liposomal composition comprising an externally disposed antigen

US5055303A
(en)

*

1989-01-31
1991-10-08
Kv Pharmaceutical Company
Solid controlled release bioadherent emulsions

WO1992020323A1
(en)

*

1991-05-16
1992-11-26
Vestar, Inc.
Methods for the administration of drugs

GB9111611D0
(en)

*

1991-05-30
1991-07-24
Sandoz Ltd
Liposomes

US5643600A
(en)

*

1991-09-17
1997-07-01
Micro-Pak, Inc.
Lipid vesicles containing avocado oil unsaponifiables

DE4131878A1
(en)

*

1991-09-25
1993-04-01
Henkel Kgaa

METHOD FOR PRODUCING LIPOSOME

WO1994021303A1
(en)

*

1993-03-16
1994-09-29
Alliance Pharmaceutical Corp.
Fluorocarbon compositions containing a visible or fluorescent label

EP0692961A1
(en)

*

1993-04-02
1996-01-24
The Liposome Company, Inc.
Method of producing liposomes

US5415869A
(en)

*

1993-11-12
1995-05-16
The Research Foundation Of State University Of New York
Taxol formulation

US5468224A
(en)

*

1993-11-30
1995-11-21
Souryal; Tarek O.
Methods of color coding injectable medications

AU693488B2
(en)

*

1993-12-15
1998-07-02
Novavax, Inc.
Lipid vesicles containing avocado oil unsaponifiables

US5716526A
(en)

*

1994-01-14
1998-02-10
The Liposome Company, Inc.
Method of separating materials from liposomes or lipid complexes

US5646131A
(en)

*

1994-02-22
1997-07-08
The Arab Company For Drug Industries And Medical Applicances (Acdima)
Method for solubilizing drugs using cyclodextrins and carboxylic acids

US5670163A
(en)

*

1994-06-20
1997-09-23
Kv Pharmaceuticals Company
Long acting GI and esophageal protectant

US5554379A
(en)

*

1994-06-20
1996-09-10
Kv Pharmaceutical Company
Long acting GI and esophageal protectant

US5595752A
(en)

*

1994-07-01
1997-01-21
Monsanto Company
Increasing dressing percentage and carcass weight in finishing beef cattle

US5672357A
(en)

*

1994-07-01
1997-09-30
Monsanto Company
Method and device for implantation of large diameter objects in bovines

US5554380A
(en)

*

1994-08-04
1996-09-10
Kv Pharmaceutical Company
Bioadhesive pharmaceutical delivery system

AU706267B2
(en)

*

1994-11-30
1999-06-10
Supergen, Inc.
Phosphocholine drug derivatives

US5711964A
(en)

*

1995-06-07
1998-01-27
United States Of America
Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D

US5756352A
(en)

*

1995-06-07
1998-05-26
Gen-Probe Incorporated
Thiocationic lipid-nucleic acid conjugates

US5739271A
(en)

*

1995-06-07
1998-04-14
Gen-Probe Incorporated
Thiocationic lipids

US5851548A
(en)

*

1995-06-07
1998-12-22
Gen-Probe Incorporated
Liposomes containing cationic lipids and vitamin D

US5759519A
(en)

*

1995-06-07
1998-06-02
Gen-Probe Incorporated
Method for the intracellular delivery of biomolecules using thiocationic lipids

US5763423A
(en)

*

1996-01-04
1998-06-09
Clarion Pharmaeuticals Inc.
Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine

JP2002514183A
(en)

*

1996-09-17
2002-05-14
スーパージェン・インコーポレーテッド

Phospholipid drug derivatives

US5830432A
(en)

*

1997-03-31
1998-11-03
Amur Pharmacuticals, Inc.
Phospholipid drug derivatives

US7169410B1
(en)

*

1998-05-19
2007-01-30
Sdg, Inc.
Targeted liposomal drug delivery system

DE10109897A1
(en)

*

2001-02-21
2002-11-07
Novosom Ag

Optional cationic liposomes and their use

CN1294271C
(en)

*

2001-02-21
2007-01-10
巴斯福股份公司
Method for production of D-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs

DE10109898A1
(en)

*

2001-02-21
2002-09-05
Novosom Gmbh

Variable charge lipids

US7858117B2
(en)

*

2002-02-21
2010-12-28
Novosom Ag
Amphoteric liposomes and their use

HU226519B1
(en)

*

2002-11-26
2009-03-30
Istvan Dr Horvath
Artificial blood made of hemoglobin encapsulated in membrane

WO2005063212A1
(en)

*

2003-12-31
2005-07-14
Amorepacific Corporation
Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same

US20070053845A1
(en)

*

2004-03-02
2007-03-08
Shiladitya Sengupta
Nanocell drug delivery system

AU2005219413A1
(en)

*

2004-03-02
2005-09-15
Massachusetts Institute Of Technology
Nanocell drug delivery system

JP2008533157A
(en)

*

2005-03-14
2008-08-21
マサチューセッツ・インスティテュート・オブ・テクノロジー

Nanocells for diagnosis and treatment of diseases and disorders

KR101172066B1
(en)

2005-09-30
2012-08-10
(주)아모레퍼시픽
Lipid-based drug delivery carrier containing stigmasteryl hemisuccinate and the composition of skin external application containing the same

US20100068264A1
(en)

*

2006-07-12
2010-03-18
University Of South Florida
Niosome-hydrogel drug delivery system

US20080317768A1
(en)

2007-06-21
2008-12-25
Boeing Company
Bioconjugated nanoparticles

US10688026B2
(en)

2009-04-27
2020-06-23
Premier Dental Products Company
Buffered microencapsulated compositions and methods

US9814657B2
(en)

*

2009-04-27
2017-11-14
Premier Dental Products Company
Buffered microencapsulated compositions and methods

US20170000875A1
(en)

*

2013-12-02
2017-01-05
Arytha Biosciences, Llc
Toxoid preparation and uses thereof

US9522114B1
(en)

2014-03-27
2016-12-20
University Of South Florida
Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin

Family Cites Families (20)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

GB1142147A
(en)

*

1965-05-28
1969-02-05
Glaxo Lab Ltd
A process for making free-flowing gel particles

US3932657A
(en)

*

1973-11-12
1976-01-13
The United States Of America As Represented By The United States Energy Research And Development Administration
Liposome encapsulation of chelating agents

DE2404047A1
(en)

*

1974-01-29
1975-08-14
Henkel & Cie Gmbh

SKIN CARE AND SKIN PROTECTION PRODUCTS WITH A CONTENT OF SKIN MOISTURIZERS

US3957971A
(en)

*

1974-07-29
1976-05-18
Lever Brothers Company
Moisturizing units and moisturizing compositions containing the same

US4040784A
(en)

*

1976-08-23
1977-08-09
Deshmukh Arvind D
Method for checking the accuracy of a test, using a serum-soluble cholesterol compound

US4183847A
(en)

*

1976-08-23
1980-01-15
Deshmukh Arvind D
Enzymatically hydrolyzable, serum-soluble cholesterol compounds and method for their preparation

US4042330A
(en)

*

1976-08-23
1977-08-16
Deshmukh Arvind D
In a method for checking the accuracy of a test using an enzymatically hydrolyzable, serum-soluble cholesterol compound

DE2860862D1
(en)

*

1977-10-13
1981-10-29
Siegfried Ag
Imidazolylethylene-oxyalkyloxy derivatives and their thio analogues, methods for their preparation and pharmaceutical compositions containing them

US4356167A
(en)

*

1978-01-27
1982-10-26
Sandoz, Inc.
Liposome drug delivery systems

US4235871A
(en)

*

1978-02-24
1980-11-25
Papahadjopoulos Demetrios P
Method of encapsulating biologically active materials in lipid vesicles

US4298594A
(en)

*

1978-04-14
1981-11-03
Arthur D. Little, Inc.
Xenobiotic delivery vehicles, method of forming them and method of using them

US4193983A
(en)

*

1978-05-16
1980-03-18
Syva Company
Labeled liposome particle compositions and immunoassays therewith

GR73668B
(en)

*

1978-11-21
1984-03-28
Hoffmann La Roche

DE3000483A1
(en)

*

1979-01-09
1980-07-17
Fuji Photo Film Co Ltd

MICROCAPSULES FOR IMMUNOLOGICAL PROVISIONS

CA1173360A
(en)

*

1979-06-22
1984-08-28
Jurg Schrank
Pharmaceutical preparations

DE3068743D1
(en)

*

1980-01-16
1984-08-30
Weder Hans G
Process and dialysis-installation for the preparation of bilayer-vesicles and their use

US4621053A
(en)

*

1980-07-30
1986-11-04
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
Process for the production of human peptide hormones

FR2521565B1
(en)

*

1982-02-17
1985-07-05
Dior Sa Parfums Christian

PULVERULENT MIXTURE OF LIPID COMPONENTS AND HYDROPHOBIC CONSTITUENTS, METHOD FOR PREPARING SAME, HYDRATED LIPID LAMELLAR PHASES AND MANUFACTURING METHOD, PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING HYDRATED LAMID PHASES

US4617161A
(en)

*

1983-09-06
1986-10-14
Baxter Travenol Laboratories, Inc.
Method of manufacture for a dialyzer having improved side ports

US4721612A
(en)

*

1984-04-12
1988-01-26
The Liposome Company, Inc.
Steroidal liposomes

1985

1985-09-10
US
US06/773,429
patent/US4891208A/en
not_active
Expired – Lifetime

1985-09-23
IE
IE233685A
patent/IE66709B1/en
not_active
IP Right Cessation

1985-09-23
CA
CA000491321A
patent/CA1262334A/en
not_active
Expired

1985-09-24
NZ
NZ213601A
patent/NZ213601A/en
unknown

1985-09-26
ES
ES547326A
patent/ES8700933A1/en
not_active
Expired

1985-10-02
PT
PT81242A
patent/PT81242B/en
not_active
IP Right Cessation

1985-10-06
IL
IL76600A
patent/IL76600A/en
not_active
IP Right Cessation

1985-10-10
WO
PCT/US1985/001983
patent/WO1986005977A1/en
active
IP Right Grant

1985-10-10
HU
HU855039A
patent/HU203205B/en
unknown

1985-10-10
AU
AU49528/85A
patent/AU596953B2/en
not_active
Expired

1985-10-10
KR
KR1019860700881A
patent/KR890001882B1/en
not_active
IP Right Cessation

1985-10-10
JP
JP60504547A
patent/JPH0798741B2/en
not_active
Expired – Lifetime

1985-10-10
EP
EP19850905180
patent/EP0222771A4/en
not_active
Withdrawn

1986

1986-04-09
ES
ES553808A
patent/ES8801085A1/en
not_active
Expired

1986-12-09
DK
DK591086A
patent/DK591086A/en
not_active
Application Discontinuation

1986-12-09
NO
NO864960A
patent/NO173213C/en
not_active
IP Right Cessation

1986-12-10
FI
FI865021A
patent/FI92463C/en
not_active
IP Right Cessation

1989

1989-11-02
AU
AU44345/89A
patent/AU609647B2/en
not_active
Expired

Also Published As

Publication number
Publication date

NO864960L
(en)

1986-12-09

KR870700347A
(en)

1987-12-28

ES547326A0
(en)

1986-11-16

FI865021A0
(en)

1986-12-10

KR890001882B1
(en)

1989-05-29

CA1262334C
(en)

1989-10-17

JPH0798741B2
(en)

1995-10-25

NO173213B
(en)

1993-08-09

AU4434589A
(en)

1990-05-17

FI92463C
(en)

1994-11-25

AU609647B2
(en)

1991-05-02

NZ213601A
(en)

1990-03-27

FI92463B
(en)

1994-08-15

FI865021A
(en)

1986-12-10

AU596953B2
(en)

1990-05-24

HUT42322A
(en)

1987-07-28

WO1986005977A1
(en)

1986-10-23

DK591086D0
(en)

1986-12-09

US4891208A
(en)

1990-01-02

CA1262334A
(en)

1989-10-17

IL76600A
(en)

1992-12-01

HU203205B
(en)

1991-06-28

PT81242B
(en)

1987-10-20

ES8801085A1
(en)

1988-01-01

DK591086A
(en)

1986-12-09

JPS62502464A
(en)

1987-09-24

ES553808A0
(en)

1988-01-01

EP0222771A4
(en)

1988-06-08

NO173213C
(en)

1993-11-17

IL76600A0
(en)

1986-02-28

ES8700933A1
(en)

1986-11-16

IE66709B1
(en)

1996-01-24

EP0222771A1
(en)

1987-05-27

IE852336L
(en)

1986-10-10

PT81242A
(en)

1985-11-01

Similar Documents

Publication
Publication Date
Title

AU4952885A
(en)

1986-11-05

Lipsomes and compositions of sterol derivatives

AU576313B2
(en)

1988-08-25

Preparation of liposomes and derivatives

AU3256189A
(en)

1989-08-03

Admixtures of steroids and drugs

AU574242B2
(en)

1988-06-30

Encapsulated halogen bleaches and methods of preparation and use

AU5960686A
(en)

1986-12-24

Imidazole analogs of mevalonolactone and derivatives thereof

AU3747485A
(en)

1985-06-26

Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

AU588365B2
(en)

1989-09-14

Pharmaceutical compositions and medical uses of dioxopiperidine derivatives

AU7828187A
(en)

1988-03-31

23-oxo (Keto) and 23-imino derivatives of LL-F28249 compounds

AU585662B2
(en)

1989-06-22

Settable compositions and methods of use thereof

AU3192389A
(en)

1989-09-06

Novel diazines and their method of preparation

AU5289686A
(en)

1987-08-06

Compositions and methods for retarding the effects of aging of the skin

AU8015587A
(en)

1988-04-28

4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols

AU578068B2
(en)

1988-10-13

Hydantoin derivatives and pharmaceutical compositions containing them

AU587802B2
(en)

1989-08-31

Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds

AU6397986A
(en)

1987-04-30

Derivatives of gamma ifn

AU2503584A
(en)

1984-09-06

C-20 and c-23 modified derivatives of tylosin

AU5606586A
(en)

1986-10-23

Pseudopterosin and derivatives

AU573524B2
(en)

1988-06-16

(n-substituted-piperazinyl) derivatives of imidazo- pyridines and pyrido-pyrazines

AU5811986A
(en)

1987-03-05

Epoxy-phosphate ceramic compositions and methods of preparation

AU7086787A
(en)

1987-09-28

Combination of aromatase inhibitors and 5alpha-reductase inhibitors

AU576717B2
(en)

1988-09-01

N6 – bicycloadenosines and methods of use

AU587814B2
(en)

1989-08-31

New derivatives of an aminoketone

AU605492B2
(en)

1991-01-17

Preparation and uses of interferon-gamma

AU570582B2
(en)

1988-03-17

Pharmaceutical composition of flupirtine and 4-acetamidophenol

AU6697086A
(en)

1987-07-02

Immunoamplifiers and related compositions

Download PDF in English

None